Checkmate Pharmaceuticals, Inc.: marketable_securities

Value{"amount": 52831000, "concept": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "currency": "USD"}
Period (as of 2020-12-31)
Statuscurrent
EntityCheckmate Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-22-088386 · Open the official SEC filing →
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001651431/marketable-securities/2020-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/fcd38ff6-be19-48fa-b8f9-009914037d7d

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies